The systemic anti-tumor efficacy of α-PD-1 treatment can be increased by it as it can promote memory recall responses for interferon-γ+ CD8+ T cells with the development of stem-like T-cell factor-1+ PD-1+ CD8+ T cells within the TME. The gene discussed is CD8A; the disease is neoplasm.